Viewing Study NCT03326258


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-02-21 @ 9:53 PM
Study NCT ID: NCT03326258
Status: WITHDRAWN
Last Update Posted: 2018-07-18
First Post: 2017-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module